Pathway enrichment analyses of upregulated genes in the lesional skin of patients with systemic sclerosis (SSc) have identified type I interferon, together with IRF and STAT families, as major upstream regulators of disease-associated transcriptional programs. This evidence concerns the gene TRIM63 and systemic sclerosis.